Cambridge, MA, United States of America

Dania Mounir Rabah

This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Biogen Ma Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dania Mounir Rabah. Retrieved from https://idiyas.com/inventor/dania-mounir-rabah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dania Mounir Rabah: Innovator in Immunological Research

Introduction

Dania Mounir Rabah is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of immunology, particularly through his innovative research and patent work.

Latest Patents

Dania holds a patent titled "Anti-blood dendritic cell antigen 2 antibodies and uses thereof." This patent discloses antibodies and antibody fragments that bind to BDCA2. The patent also outlines methods for using these antibodies and fragments to induce the death of plasmacytoid dendritic cells, inhibit the production or secretion of inflammatory cytokines and chemokines, and treat or prevent immunological disorders such as inflammatory and autoimmune conditions. He has 1 patent to his name.

Career Highlights

Dania is currently employed at Biogen MA Inc., where he continues to advance his research in immunological therapies. His work has the potential to impact the treatment of various autoimmune and inflammatory diseases.

Collaborations

Dania collaborates with notable colleagues, including Justin Andrew Caravella and Ellen A Garber Stark, who contribute to his research endeavors.

Conclusion

Dania Mounir Rabah is a prominent figure in the field of immunology, with a focus on developing innovative therapies for immunological disorders. His contributions through patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…